Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae

Sexually Transmitted Diseases

Volumn 38, Issue 2, 2011, Pages 82-88

  Ruddock, Patrick S ^a   Charland, Marijo ^a   Ramirez, Sandra ^a   López, Andres ^b   Towers, G H Neil ^b   Arnason, John T ^a   Liao, Mingmin ^a   Dillon, Jo Anne R ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2',4',6' TRIHYDROXYCHALCONE; ADIANTUM LATIFOLIUM EXTRACT; AMPELOZIZYPHUS AMAZONICUS EXTRACT; BENZOIC ACID DERIVATIVE; BYRSONIMA VERBASCIFOLIA EXTRACT; CONYZA BONARIENSIS EXTRACT; CYCLOLANCEAEFOLIC ACID METHYL ESTER; DUROIA HIRSUTA EXTRACT; ESCHWEILERA RUTIFOLIA EXTRACT; EUPATORIUM GLUTINOSUM EXTRACT; FLAVONOID; IRYANTHERA MEGISTOPHYLLA EXTRACT; IRYANTHERA TRICORNIS EXTRACT; MYRTEOLA NUMMULARIA EXTRACT; PICROLEMNA SPRUCEI EXTRACT; PINOCEMBRINE; PIPER LANCEAEFOLIUM EXTRACT; PLANT EXTRACT; POLYGONUM PUNCTATUM EXTRACT; SENNA RETICULATA EXTRACT; SOLANUM NIGRUM EXTRACT; SYMPHONIA GLOBULIFERA EXTRACT; TAGETES ERECTA EXTRACT; UNCLASSIFIED DRUG; VIROLA MULTINERVIA EXTRACT; VISMIA MACROPHYLLA EXTRACT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; COLOMBIA; CONTROLLED STUDY; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PIPER LANCEAEFOLIUM; SCREENING; SKIN INFECTION; TRADITIONAL MEDICINE; ULTRAVIOLET RADIATION;

ANTI-BACTERIAL AGENTS; CHALCONES; COLOMBIA; DRUG RESISTANCE, BACTERIAL; FLAVANONES; FLAVONOIDS; HUMANS; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PIPER; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 78751642254     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181f0bdbd     Document Type: Article

References (44)

1. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148:606-613.
2. Sefton AM. Mechanisms of antimicrobial resistance-their clinical relevance in the new millennium. Drugs 2002; 62:557-566.
3. Tapsall JW. Current concepts in the management of gonorrhoea. Expert Opin Pharmacol 2002; 3:147-157.
4. Ison CA, Dillon JR, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Hae-mophilus ducreyi. Lancet 1998; 351:8-11.
5. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother 2009; 64(suppl 1):129-136.
6. Dillon JR, Pagotto F. Importance of drug resistance in gonococci: From mechanisms to monitoring. Curr Opin Infect Dis 1999; 2:35-40.
7. Greco V, Ng LK, Catana R, et al. Molecular epidemiology of Neisseria gonorrhoeae isolates with plasmid-mediated tetracy-cline resistance in Canada: Temporal and geographical trends (1986-1997). Microb Drug Resist 2003; 9:353-360.
8. Dillon JR, Ruben M, Li H, et al. Challenges in the control of gonorrhea in South America and the Caribbean: Monitoring the development of resistance to antibiotics. Sex Transm Dis 2008; 39:87-95.
9. Farhi D, Dupin N. The rise of fluoroquinolone-resistant Neisseria gonorrhoeae. Swiss Med Wkly 2008; 138:223-224.
10. Farhi D, Hotz C, Poupet H, et al. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: Implications for treatment guidelines. Acta Derm Venereol 2009; 89:484-487.
11. Yang Y, Liao M, Gu WM, et al. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gon-orrhoeae isolates from Shanghai. J Antimicrob Chemother 2006; 58:868-872.
12. Plitt S, Bovington C, Sutherland K, et al. Antimicrobial resistance in gonorrhoea: The influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001- 2007. Sex Transm Dis 2009; 36:665-669.
13. Ito M, Yasuda M, Yokoi S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalospo-rins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48:3185-3187.
14. Tapsall J, Read P, Carmody C, et al. Two cases of failed ceftri-axone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 2009; 58:683-687.
15. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis 2009; 1:87-91.
16. Sosa J, Ramirez-Arcos S, Ruben M, et al. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neis-seria gonorrhoeae isolates in Cuba, 1995-1998. Sex Transm Dis 2003; 30:443-448.
17. Chislom SA, Neal TJ, Alawattegamma AB, et al. Emergence of high level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother 2009; 64:353-358.
18. Lundback D, Fredlund H, Berglund T, et al. Molecular epidemiology of Neisseria gonorrhoeae-Identification of the first presumed Swedish transmission chain of an azithromycin-resistant strain. APMIS 2006; 114:67-71.
19. Rios JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol 2005; 100:80-84.
20. Caceres A, Menendez H, Mendez E, et al. Antigonorrhoeal activity of plants used in Guatemala for treatment of sexually transmitted diseases. J Ethnopharmacol 1995; 48:85-88.
21. Kambizi L, Afolayan AJ. An ethnobotanical study of plants used for the treatment of STDs (njovhera) in Guruve District, Zimbabwe. J Ethnopharmacol 2001; 77:5-9.
22. Silva O, Ferreira E, Vaz Pato M, et al. In vitro anti-Neisseria gonorrhoeae activity of Terminalia macroptera leaves. FEMS Microbiol Lett 2002; 217:271-274.
23. Swart H, Van Dyck S, Malan SF. The activity of p-methoxyben- zylisothiocyanate against Neisseria gonorrhoeae, Haemophilus ducreyi and other microorganisms. Bioorg Med Chem Lett 2005; 12:2435-2437.
24. Ruddock PS, Liao M, Foster BC, et al. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. Phytother Res 2005; 19:327-334.
25. Shokeen P, Ray K, Bala M, et al. Preliminary studies on activity of Ocimum sanctum, Drynaria quercifolia, and Annona squa-mosa against Neisseria gonorrhoeae. Sex Transm Dis 2005; 32:106-111.
26. Silva MT, Simas SM, Batista TG, et al. Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination. Mem Inst Oswaldo Cruz 2005; 100:779-782.
27. Tshikalange TE, Meyer JJ, Hussein AA. Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J Ethnopharmacol 2005; 96:515-519.
28. Buwa LV, van Staden J. Antibacterial and antifungal activity of traditional medicinal plants used against venereal diseases in South Africa. J Ethnopharmacol 2005; 103:139-142.
29. López A, Hudson JB, Towers GH. Antiviral and antimicrobial activities of Colombian medicinal plants. J Ethnopharmacol 2001; 77:189-196.
30. World Health Organization. Laboratory diagnosis of gonorrhoea. Geneva, Switzerland: WHO regional publication, 2001: 37. South-East Asia Series No 33.
31. National Committee for Clinical Laboratory Standards. Methods for dilution-antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. M7-A6. Wayne, PA: NCCLS, 2003.
32. Ng LK, Dillon JR. Typing by serovar, antibiogram, plasmid content, riboprobing and isoenzyme typing to determine whether Neisseria gonorrhoeae isolates requiring proline, citrulline, and uracil for growth are clonal. J Clin Microbiol 1993; 31:1555-1561.
33. López A, Ming DS, Towers GH. Antifungal activity of benzoic acid derivatives from Piper lanceaefolium. J Nat Prod 2002; 65:62-64.
34. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th ed. M2-A7. Wayne, PA: NCCLS, 2000.
35. Binns SE, Purgina B, Bergeron C, et al. Light mediated anti-fungal activity of Echinacea extracts. Planta Med 2000; 66: 241-244.
36. Alcaráz LE, Blanco SE, Puig ON, et al. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains. J Theor Biol 2000; 205:231-240.
37. Bremner PD, Meyer JJ. Pinocembrin chalcone: An antimicrobial compound from Helichrysum trilineatum. Planta Med 1998; 64: 777.
38. Garg SC, Dengre SL. Antibacterial activity of essential oils of Tagetes erecta Linn. Hindustan Antibiot Bull 1986; 28:27-29.
39. Penna C, Marino S, Vivot E, et al. Antimicrobial activity of Argentine plants used in the treatment of infectious diseases. Isolation of active compounds from Sebastiania brasiliensis. J Ethnopharmacol 2001; 77:37-40.
40. El-Seedi HR, Ohara T, Sata N, et al. Antimicrobial diterpenoids from Eupatorium glutinosum (Asteraceae). J Ethnopharmacol 2002; 81:293-296.
41. Ming DS, López A, Hillhouse BJ, et al. Bioactive constituents from Iryanthera megistophylla. J Nat Prod 2002; 65:1412-1416.
42. Nkengfack AE, Mkounga P, Meyer M, et al. Globulixanthones C, D and E: Three prenylated xanthones with antimicrobial properties from the root bark of Symphonia globulifera. Phytochemistry 2002; 61:181-187. (Pubitemid 34976885)
43. Ngouela S, Ndjakou BL, Tchamo DN, et al. A prenylated xan-thone with antimicrobial activity from the seeds of Symphonia globulifera. Nat Prod Res 2005; 19:23-27.
44. Fukui H, Goto K, Tabata M. Two antimicrobial flavanones from the leaves of Glycyrrhiza glabra. Chem Pharm Bull (Tokyo) 1988; 36:4174-4176.